# Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma

> **NCT00314873** · PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 11 (actual)

## Conditions studied

- Thymic Carcinoma

## Interventions

- **DRUG:** Gleevec (imatinib)

## Key facts

- **NCT ID:** NCT00314873
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314873, "Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00314873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*